Literature DB >> 22525336

Onconase downregulates microRNA expression through targeting microRNA precursors.

Meng Qiao, Li-Dong Zu, Xiao-Hong He, Ru-Ling Shen, Qing-Cheng Wang, Mo-Fang Liu.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22525336      PMCID： PMC3391012          DOI： 10.1038/cr.2012.67

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  17 in total

Review 1.  Ranpirnase--an antitumour ribonuclease: its potential role in malignant mesothelioma.

Authors:  Nick Pavlakis; Nicholas J Vogelzang
Journal:  Expert Opin Biol Ther       Date:  2006-04       Impact factor: 4.388

2.  MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors.

Authors:  Paolo Romania; Valentina Lulli; Elvira Pelosi; Mauro Biffoni; Cesare Peschle; Giovanna Marziali
Journal:  Br J Haematol       Date:  2008-11       Impact factor: 6.998

3.  MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta.

Authors:  Min He; Zhenqun Xu; Tong Ding; Dong-Ming Kuang; Limin Zheng
Journal:  Cell Mol Immunol       Date:  2009-10       Impact factor: 11.530

Review 4.  Ribonucleases as novel chemotherapeutics : the ranpirnase example.

Authors:  J Eugene Lee; Ronald T Raines
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

5.  Transfer RNA cleavages by onconase reveal unusual cleavage sites.

Authors:  Avvaru N Suhasini; Ravi Sirdeshmukh
Journal:  J Biol Chem       Date:  2006-02-23       Impact factor: 5.157

6.  G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation.

Authors:  G Juan; B Ardelt; X Li; S M Mikulski; K Shogen; W Ardelt; A Mittelman; Z Darzynkiewicz
Journal:  Leukemia       Date:  1998-08       Impact factor: 11.528

7.  MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene.

Authors:  Z Lu; M Liu; V Stribinskis; C M Klinge; K S Ramos; N H Colburn; Y Li
Journal:  Oncogene       Date:  2008-03-31       Impact factor: 9.867

8.  Ribonuclease inhibitor as an intracellular sentry.

Authors:  Marcia C Haigis; Erin L Kurten; Ronald T Raines
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

9.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.

Authors:  Fanyin Meng; Roger Henson; Hania Wehbe-Janek; Kalpana Ghoshal; Samson T Jacob; Tushar Patel
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

10.  Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice.

Authors:  Stefan Costinean; Sukhinder K Sandhu; Irene M Pedersen; Esmerina Tili; Rossana Trotta; Danilo Perrotti; David Ciarlariello; Paolo Neviani; Jason Harb; Lauren Rachel Kauffman; Aaditya Shidham; Carlo Maria Croce
Journal:  Blood       Date:  2009-06-11       Impact factor: 22.113
View more
  16 in total

1.  Recombinant expression, different downstream processing of the disulfide-rich anti-tumor peptide Ranpirnase and its effect on the growth of human glioma cell line SHG-44.

Authors:  Xiao-Min Wang; Zhan-Yun Guo
Journal:  Biomed Rep       Date:  2013-07-17

Review 2.  Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections.

Authors:  Marta Menegazzi; Giovanni Gotte
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

3.  Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platform.

Authors:  Thomas Schirrmann; André Frenzel; Lars Linden; Beatrix Stelte-Ludwig; Jörg Willuda; Axel Harrenga; Stefan Dübel; Beate Müller-Tiemann; Mark Trautwein
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

4.  Ribonuclease binase inhibits primary tumor growth and metastases via apoptosis induction in tumor cells.

Authors:  Nadezhda L Mironova; Irina Y Petrushanko; Olga A Patutina; Aexandra V Sen'kova; Olga V Simonenko; Vladimir A Mitkevich; Oleg V Markov; Marina A Zenkova; Alexander A Makarov
Journal:  Cell Cycle       Date:  2013-06-10       Impact factor: 4.534

Review 5.  Discovery of antitumor effects of leczymes.

Authors:  Takeo Tatsuta; Masahiro Hosono
Journal:  Glycoconj J       Date:  2022-01-23       Impact factor: 2.916

6.  MicroRNA drop in the bloodstream and microRNA boost in the tumour caused by treatment with ribonuclease A leads to an attenuation of tumour malignancy.

Authors:  Nadezhda Mironova; Olga Patutina; Evgenyi Brenner; Alexander Kurilshikov; Valentin Vlassov; Marina Zenkova
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

7.  A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.

Authors:  Anna Vert; Jessica Castro; Marc Ribó; Antoni Benito; Maria Vilanova
Journal:  Oncotarget       Date:  2016-04-05

8.  Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase.

Authors:  Anna Vert; Jessica Castro; Marc Ribó; Antoni Benito; Maria Vilanova
Journal:  Oncotarget       Date:  2017-02-14

Review 9.  Immune Modulation by Human Secreted RNases at the Extracellular Space.

Authors:  Lu Lu; Jiarui Li; Mohammed Moussaoui; Ester Boix
Journal:  Front Immunol       Date:  2018-05-16       Impact factor: 7.561

10.  The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy.

Authors:  Nadezhda Mironova; Olga Patutina; Evgenyi Brenner; Alexander Kurilshikov; Valentin Vlassov; Marina Zenkova
Journal:  Oncotarget       Date:  2017-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.